Matches in SemOpenAlex for { <https://semopenalex.org/work/W33448001> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W33448001 startingPage "123" @default.
- W33448001 abstract "I-131-MIBG is used to image and treat human pheochrmocytoma. As part of a pharmacodynamic study, the authors have evaluated its excretion and metabolism in 8 pheochromocytoma patients undergoing MIBG therapy. Following diagnostic doses (0.42-0.53 mCi) of I-131-MIBG given prior to therapy, 40-55% of the administered radioactivity appears in the urine within 24 h with 70-90% recoverable within 4 days. HPLC was used to identify potential metabolites following therapeutic doses (130-213 mCi) of I-131-NIBG. Aliquots of daily urine samples were prepared for HPLC analysis by passage through C-18 Sep-pak cartridges. A reverse-phase HPLC system (..mu..Bondapak C-18; 0.2 M ammonium phosphate/THF, 80/20) with both ultraviolet (254 nm) and radioactive (Flo-one detector, solid scintillant cell) detection was used. Radioactive metabolites were identified by co-chromatography with authentic compounds at elution solvent pH's of 4.6 and 7.0. Unaltered I-131-MIBG was the primary radioactive urinary component in all 8 patients studied, representing 74-90% of the total recovered. Two ''major'' metabolites were identified: I-131-iodide and I-131-m-iodohippuric acid, representing, respectively, 2-6% and 2-16% of the total urinary radioactivity. Of 4 additional ''minor'' metabolites (< 2% of total urinary radioactivity) detected, 2 have been identified: I-131-4-hydroxy-MIBG and I-131-m-iodobenzoic acid. The 4-5 day metabolism profiles varied from patient to patientmore » but did not change in 2 patients given 2 therapy doses 4 months apart. No obvious correlation was observed between the presence of metabolites and the location of the tumors or the plasma or urinary catecholamine levels. I-131-MIBC is a rapidly excreted, relatively stable radiopharmaceutical agent.« less" @default.
- W33448001 created "2016-06-24" @default.
- W33448001 creator A5015046812 @default.
- W33448001 creator A5035317276 @default.
- W33448001 creator A5056815788 @default.
- W33448001 creator A5067170977 @default.
- W33448001 date "1984-01-01" @default.
- W33448001 modified "2023-10-18" @default.
- W33448001 title "Metabolism of I-131-meta-iodobenzylguanidine (MIBG) in humans" @default.
- W33448001 hasPublicationYear "1984" @default.
- W33448001 type Work @default.
- W33448001 sameAs 33448001 @default.
- W33448001 citedByCount "0" @default.
- W33448001 crossrefType "journal-article" @default.
- W33448001 hasAuthorship W33448001A5015046812 @default.
- W33448001 hasAuthorship W33448001A5035317276 @default.
- W33448001 hasAuthorship W33448001A5056815788 @default.
- W33448001 hasAuthorship W33448001A5067170977 @default.
- W33448001 hasConcept C10146269 @default.
- W33448001 hasConcept C126322002 @default.
- W33448001 hasConcept C177322064 @default.
- W33448001 hasConcept C179998833 @default.
- W33448001 hasConcept C185592680 @default.
- W33448001 hasConcept C2777477808 @default.
- W33448001 hasConcept C2780026642 @default.
- W33448001 hasConcept C43617362 @default.
- W33448001 hasConcept C55493867 @default.
- W33448001 hasConcept C62231903 @default.
- W33448001 hasConcept C71924100 @default.
- W33448001 hasConcept C77411442 @default.
- W33448001 hasConceptScore W33448001C10146269 @default.
- W33448001 hasConceptScore W33448001C126322002 @default.
- W33448001 hasConceptScore W33448001C177322064 @default.
- W33448001 hasConceptScore W33448001C179998833 @default.
- W33448001 hasConceptScore W33448001C185592680 @default.
- W33448001 hasConceptScore W33448001C2777477808 @default.
- W33448001 hasConceptScore W33448001C2780026642 @default.
- W33448001 hasConceptScore W33448001C43617362 @default.
- W33448001 hasConceptScore W33448001C55493867 @default.
- W33448001 hasConceptScore W33448001C62231903 @default.
- W33448001 hasConceptScore W33448001C71924100 @default.
- W33448001 hasConceptScore W33448001C77411442 @default.
- W33448001 hasIssue "5" @default.
- W33448001 hasLocation W334480011 @default.
- W33448001 hasOpenAccess W33448001 @default.
- W33448001 hasPrimaryLocation W334480011 @default.
- W33448001 hasRelatedWork W1482445821 @default.
- W33448001 hasRelatedWork W1569963755 @default.
- W33448001 hasRelatedWork W1580119287 @default.
- W33448001 hasRelatedWork W1834599302 @default.
- W33448001 hasRelatedWork W1967299205 @default.
- W33448001 hasRelatedWork W1983452511 @default.
- W33448001 hasRelatedWork W1990343665 @default.
- W33448001 hasRelatedWork W1997230207 @default.
- W33448001 hasRelatedWork W2007291959 @default.
- W33448001 hasRelatedWork W2014752206 @default.
- W33448001 hasRelatedWork W2027480096 @default.
- W33448001 hasRelatedWork W2033766451 @default.
- W33448001 hasRelatedWork W2043320507 @default.
- W33448001 hasRelatedWork W2072605501 @default.
- W33448001 hasRelatedWork W2113841160 @default.
- W33448001 hasRelatedWork W2263695696 @default.
- W33448001 hasRelatedWork W2317088350 @default.
- W33448001 hasRelatedWork W2324273597 @default.
- W33448001 hasRelatedWork W2402119253 @default.
- W33448001 hasRelatedWork W2423459061 @default.
- W33448001 hasVolume "25" @default.
- W33448001 isParatext "false" @default.
- W33448001 isRetracted "false" @default.
- W33448001 magId "33448001" @default.
- W33448001 workType "article" @default.